These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28937269)

  • 1. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
    Sun Myint A; Smith FM; Gollins SW; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman MJ; Fekete Z; Perkins K; Pritchard DM
    Br J Radiol; 2017 Dec; 90(1080):20170175. PubMed ID: 28937269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
    Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
    Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
    Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of radiotherapy in the treatment of rectal cancer in older patients.
    Myint AS; Gérard JP
    Eur J Surg Oncol; 2020 Mar; 46(3):349-357. PubMed ID: 31926607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer.
    Than NW; Pritchard DM; Hughes DM; Duckworth CA; Wong H; Haq MU; Sripadam R; Myint AS
    Radiother Oncol; 2024 Oct; 199():110465. PubMed ID: 39074538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact X-ray brachytherapy (CXB) as a salvage treatment for rectal cancer patients who developed local tumor re-growth after watch-and-wait approach.
    Than NW; Pritchard DM; Duckworth CA; Hughes DM; Wong H; Sripadam R; Myint AS
    J Contemp Brachytherapy; 2024 Apr; 16(2):95-102. PubMed ID: 38808203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
    Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
    Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
    Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer.
    Garant A; Magnan S; Devic S; Martin AG; Boutros M; Vasilevsky CA; Ferland S; Bujold A; DesGroseilliers S; Sebajang H; Richard C; Vuong T
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1005-1011. PubMed ID: 31476417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
    Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact X-ray Brachytherapy as an Adjunct to a Watch and Wait Approach is an Affordable Alternative to Standard Surgical Management of Rectal Cancer for Patients with a Partial Clinical Response to Chemoradiotherapy.
    Rao C; Stewart A; Martin AP; Collins B; Pritchard DM; Athanasiou T; Sun Myint A
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):625-633. PubMed ID: 30196845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
    Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
    Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy.
    Rao C; Smith FM; Martin AP; Dhadda AS; Stewart A; Gollins S; Collins B; Athanasiou T; Sun Myint A
    Clin Oncol (R Coll Radiol); 2018 Mar; 30(3):166-177. PubMed ID: 29248311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
    Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305
    [No Abstract]   [Full Text] [Related]  

  • 17. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study.
    Wah Than N; Mark Pritchard D; Hughes DM; Shing Yu K; Minnaar HS; Dhadda A; Mills J; Folkesson J; Radu C; Duckworth CA; Wong H; Ul Haq M; Sripadam R; Halling-Brown MD; Stewart AJ; Sun Myint A
    Clin Transl Radiat Oncol; 2024 Nov; 49():100851. PubMed ID: 39308635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low energy contact X-ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales.
    Bennett H; Rao C; Batten L; Hasler E; Jarrom D; Prettyjohns M; Barrington C; Sun Myint A
    Colorectal Dis; 2024 May; 26(5):1053-1058. PubMed ID: 38467574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.
    Gerard JP; Myint AS; Barbet N; Dejean C; Thamphya B; Gal J; Montagne L; Vuong T
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.